|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-09-19 |
4 |
OE |
$45.11 |
$2,601,285 |
D/D |
52,500 |
110,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
OE |
$45.11 |
$191,718 |
D/D |
4,250 |
121,514 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-04-27 |
4 |
OE |
$45.11 |
$3,000,404 |
D/D |
50,875 |
188,995 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-08-05 |
4 |
OE |
$45.11 |
$1,168,141 |
D/D |
19,828 |
147,343 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-09-04 |
4 |
OE |
$53.74 |
$487,046 |
D/D |
9,063 |
136,578 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-05 |
4 |
OE |
$45.11 |
$301,889 |
D/D |
6,264 |
111,012 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
OE |
$77.31 |
$282,182 |
D/D |
3,650 |
108,541 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-12-04 |
4 |
OE |
$53.74 |
$243,496 |
D/D |
4,531 |
108,995 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-04-28 |
4 |
OE |
$45.11 |
$1,277,515 |
D/D |
28,320 |
159,567 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-01 |
4 |
OE |
$53.74 |
$730,542 |
D/D |
13,594 |
145,061 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-02 |
4 |
OE |
$77.31 |
$4,628,505 |
D/D |
57,375 |
188,842 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-19 |
4 |
OE |
$91.05 |
$9,587,718 |
D/D |
89,400 |
220,867 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-21 |
4 |
OE |
$131.89 |
$280,266 |
D/D |
2,125 |
133,592 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-31 |
4 |
OE |
$83.36 |
$177,140 |
D/D |
2,125 |
123,242 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-27 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
119,077 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
46,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-11 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
46,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
44,077 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-24 |
4 |
OE |
$86.52 |
$795,522 |
D/D |
8,969 |
50,921 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-02 |
4 |
OE |
$91.05 |
$196,304 |
D/D |
2,156 |
44,108 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-05 |
4 |
OE |
$77.31 |
$792,413 |
D/D |
8,500 |
50,452 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-04-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
48,877 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-22 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
51,002 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|